INmune Bio (INMB) Institutional Ownership $2.41 +0.06 (+2.55%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.36 -0.05 (-2.03%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for INmune Bio (NASDAQ:INMB)CurrentInstitutional OwnershipPercentage12.72%Number ofInstitutional Buyers(last 12 months)45TotalInstitutional Inflows(last 12 months)$12.09MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$4.35M Get INMB Insider Trade Alerts Want to know when executives and insiders are buying or selling INmune Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INMB Institutional Buying and Selling by Quarter INmune Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Oxford Asset Management LLP22,490$52K0.0%N/A0.085% 8/15/2025 Bank of America Corp DE12,173$28K0.0%-59.9%0.046% 8/14/2025 Raymond James Financial Inc.333,477$770K0.0%-12.7%1.255% 8/14/2025 Praetorian PR LLC5,904$49K0.0%-99.3%0.022% 8/12/2025 XTX Topco Ltd125,847$291K0.0%+240.9%0.473% 8/12/2025 MAI Capital Management48,238$111K0.0%-54.8%0.181% 8/12/2025 JPMorgan Chase & Co.73,097$169K0.0%+1,042.7%0.275% 8/8/2025 Intech Investment Management LLC11,327$26K0.0%N/A0.048% 8/8/2025 Geode Capital Management LLC389,931$901K0.0%+6.9%1.654% 8/8/2025 PNC Financial Services Group Inc.37,715$87K0.0%N/A0.160% Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 8/6/2025 Modera Wealth Management LLC15,455$36K0.0%N/A0.066% 8/5/2025 Westside Investment Management Inc.21,375$49K0.0%-76.0%0.091% 7/31/2025 Focus Partners Advisor Solutions LLC48,813$113K0.0%+321.2%0.207% 7/18/2025 PFG Investments LLC11,500$27K0.0%N/A0.049% 6/27/2025 Goldman Sachs Group Inc.40,716$318K0.0%-36.0%0.177% 5/29/2025 Rhumbline Advisers19,153$150K0.0%+14.4%0.083% 5/19/2025 Jane Street Group LLC18,159$142K0.0%N/A0.079% 5/16/2025 Goldman Sachs Group Inc.40,716$318K0.0%-36.0%0.177% 5/16/2025 PharVision Advisers LLC17,241$135K0.2%N/A0.075% 5/15/2025 Focus Partners Advisor Solutions LLC11,589$91K0.0%N/A0.050% 5/15/2025 Royal Bank of Canada29,863$233K0.0%+44.8%0.130% 5/15/2025 MAI Capital Management106,797$834K0.0%+6.0%0.465% 5/15/2025 Quarry LP6,093$48K0.0%N/A0.027% 5/14/2025 Hsbc Holdings PLC19,385$145K0.0%-23.1%0.084% 5/13/2025 Raymond James Financial Inc.382,041$2.98M0.0%-19.7%1.662% 5/12/2025 Nuveen LLC16,518$129K0.0%N/A0.072% 5/9/2025 Deutsche Bank AG38,011$297K0.0%-65.4%0.165% 5/9/2025 Charles Schwab Investment Management Inc.41,320$323K0.0%+19.2%0.180% 5/8/2025 XTX Topco Ltd36,919$288K0.0%-39.7%0.161% 4/30/2025 Pekin Hardy Strauss Inc.94,300$736K0.1%+13.1%0.410% 4/29/2025 Bank of New York Mellon Corp54,923$429K0.0%+9.0%0.239% 4/22/2025 Cambridge Investment Research Advisors Inc.23,075$180K0.0%N/A0.101% 4/10/2025 Fermata Advisors LLC49,997$390K0.1%+6.4%0.218% 4/8/2025 Rhumbline Advisers19,153$150K0.0%+14.4%0.084% 2/17/2025 Two Sigma Advisers LP12,700$59K0.0%N/A0.057% 2/17/2025 Two Sigma Investments LP66,384$310K0.0%+444.8%0.299% 2/17/2025 Millennium Management LLC291,327$1.36M0.0%+43.9%1.314% 2/17/2025 Laird Norton Wetherby Trust Company LLC34,100$159K0.0%+3.8%0.154% 2/17/2025 Bank of America Corp DE30,449$142K0.0%+15.2%0.137% 2/17/2025 BNP Paribas Financial Markets25,513$119K0.0%+799.9%0.115% Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th.2/14/2025 Northern Trust Corp105,961$495K0.0%+9.5%0.478% 2/14/2025 Beacon Pointe Advisors LLC10,368$48K0.0%N/A0.047% 2/14/2025 Dauntless Investment Group LLC191,822$896K0.9%N/A0.865% 2/14/2025 Hsbc Holdings PLC25,211$119K0.0%+34.2%0.114% 2/14/2025 Dimensional Fund Advisors LP25,139$117K0.0%+71.6%0.113% 2/13/2025 Marshall Wace LLP77,468$362K0.0%-3.0%0.349% 2/13/2025 Walleye Capital LLC33,719$157K0.0%N/A0.152% 2/13/2025 XTX Topco Ltd61,271$286K0.0%+32.5%0.276% 2/13/2025 Mariner LLC13,836$65K0.0%N/A0.062% 2/13/2025 Barclays PLC32,019$150K0.0%+10.2%0.144% 2/13/2025 Raymond James Financial Inc.475,551$2.22M0.0%N/A2.145% 2/13/2025 Renaissance Technologies LLC185,800$868K0.0%+73.3%0.838% 2/13/2025 Wells Fargo & Company MN6,377$30K0.0%+51.0%0.029% 2/12/2025 Geode Capital Management LLC363,602$1.70M0.0%+5.6%1.640% 2/12/2025 Diametric Capital LP36,699$171K0.1%+24.6%0.166% 2/12/2025 JPMorgan Chase & Co.11,335$53K0.0%+93.0%0.051% 2/11/2025 LPL Financial LLC19,072$89K0.0%+33.0%0.086% 2/6/2025 Raymond James Financial Inc.475,551$2.22M0.0%N/A2.145% 1/30/2025 Rhumbline Advisers16,744$78K0.0%+16.9%0.076% 1/27/2025 Financial Advocates Investment Management15,500$72K0.0%+14.8%0.070% 1/17/2025 Westside Investment Management Inc.89,975$420K0.1%+26.2%0.406% 1/15/2025 Fermata Advisors LLC46,997$219K0.0%+10.0%0.212% 11/25/2024Sanctuary Advisors LLC21,045$113K0.0%N/A0.095% 11/20/2024 Westside Investment Management Inc.71,315$384K0.1%+57.3%0.322% 11/19/2024 Barclays PLC29,044$157K0.0%+601.9%0.131% 11/16/2024 Geode Capital Management LLC344,466$1.86M0.0%+6.6%1.554% 11/15/2024 Barclays PLC29,044$157K0.0%+601.9%0.131% 11/15/2024 XTX Topco Ltd46,253$249K0.0%N/A0.209% 11/15/2024 Jane Street Group LLC14,725$79K0.0%N/A0.066% 11/15/2024 State Street Corp226,428$1.22M0.0%+35.1%1.021% 11/14/2024 Praetorian PR LLC780,800$4.21M1.6%+61.0%3.522% 11/12/2024 Charles Schwab Investment Management Inc.33,990$183K0.0%-8.8%0.153% 10/25/2024 Financial Advocates Investment Management13,500$73K0.0%+17.4%0.068% 10/9/2024 Fermata Advisors LLC42,730$230K0.0%+25.2%0.216% 8/15/2024CVI Holdings LLC596,372$5.26M4.8%N/A3.015% 8/14/2024 Marshall Wace LLP115,916$1.02M0.0%+332.1%0.586% 8/1/2024 Rhumbline Advisers13,773$121K0.0%N/A0.070% 7/26/2024 Bank of New York Mellon Corp58,600$517K0.0%+124.6%0.296% 7/17/2024 Westside Investment Management Inc.45,340$400K0.1%+31.8%0.229% 7/13/2024 Fermata Advisors LLC34,140$301K0.1%+8.5%0.173% 5/1/2024 Janney Montgomery Scott LLC140,911$1.66M0.0%-13.8%0.774% 4/19/2024 Westside Investment Management Inc.34,390$404K0.1%-17.9%0.189% 4/12/2024 Fermata Advisors LLC31,451$370K0.1%+6.9%0.174% 2/8/2024 Financial Advocates Investment Management12,500$141K0.0%+8.6%0.069% 2/8/2024 Janney Montgomery Scott LLC163,559$1.84M0.0%-36.3%0.908% 1/19/2024 Fermata Advisors LLC29,426$331K0.1%-48.1%0.163% 11/9/2023 Rhenman & Partners Asset Management AB50,000$338K0.0%-72.0%0.277% 11/9/2023 Deutsche Bank AG109,848$744K0.0%-9.3%0.610% 11/8/2023 Janney Montgomery Scott LLC256,887$1.74M0.0%+14.5%1.426% 11/7/2023 Fermata Advisors LLC56,702$384K0.1%N/A0.315% Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th.10/24/2023 Bank of New York Mellon Corp32,891$223K0.0%N/A0.183% 8/11/2023 Rhenman & Partners Asset Management AB178,284$1.62M0.2%N/A0.989% 8/2/2023 MAI Capital Management59,177$537K0.0%+201.3%0.330% 7/26/2023 Janney Montgomery Scott LLC224,405$2.04M0.0%-6.3%1.250% 7/24/2023 Meitav Investment House Ltd.181,140$6.65M0.1%N/A1.009% 7/14/2023 Westside Investment Management Inc.42,240$384K0.1%+13.8%0.235% 5/11/2023 Financial Advocates Investment Management11,500$74K0.0%-15.8%0.064% 5/10/2023 MAI Capital Management19,643$127K0.0%N/A0.109% 4/28/2023 Janney Montgomery Scott LLC239,448$1.55M0.0%+6.6%1.334% 2/3/2023 Sepio Capital LP23,200$147K0.0%-4.9%0.129% (Data available from 1/1/2016 forward) INMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INMB shares? During the previous two years, 51 institutional investors and hedge funds held shares of INmune Bio. The most heavily invested institutionals were CVI Holdings LLC ($5.26M), Janney Montgomery Scott LLC ($1.66M), Millennium Management LLC ($1.36M), State Street Corp ($1.22M), Geode Capital Management LLC ($901K), Dauntless Investment Group LLC ($896K), and Renaissance Technologies LLC ($868K).Learn more on INmune Bio's institutional investors. What percentage of INmune Bio's stock is owned by institutional investors? 12.72% of INmune Bio's stock is owned by institutional investors. Learn more on INMB's institutional investor holdings. Which institutional investors have been buying INmune Bio's stock? Of the 48 institutional investors that purchased INmune Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Raymond James Financial Inc. ($951.10K), CVI Holdings LLC ($596.37K), Praetorian PR LLC ($295.80K), Dauntless Investment Group LLC ($191.82K), XTX Topco Ltd ($150.20K), Marshall Wace LLP ($89.09K), and Millennium Management LLC ($88.82K). How much institutional buying is happening at INmune Bio? Institutional investors have bought a total of 2,571,841 shares in the last 24 months. This purchase volume represents approximately $12.09M in transactions. Which of INmune Bio's major shareholders have been selling company stock? Of the 11 institutional investors that sold INmune Bio's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Praetorian PR LLC ($863K), Raymond James Financial Inc. ($142.07K), Deutsche Bank AG ($71.84K), Westside Investment Management Inc. ($67.83K), MAI Capital Management ($58.56K), Goldman Sachs Group Inc. ($45.80K), and XTX Topco Ltd ($24.35K). How much institutional selling is happening at INmune Bio? Institutional investors have sold a total of 1,303,196 shares in the last 24 months. This volume of shares sold represents approximately $4.35M in transactions. Related Companies Lifecore Biomedical Institutional Ownership Monte Rosa Therapeutics Institutional Ownership DBV Technologies Institutional Ownership Atea Pharmaceuticals Institutional Ownership Sagimet Biosciences Institutional Ownership ADC Therapeutics Institutional Ownership Prima BioMed Institutional Ownership Galectin Therapeutics Institutional Ownership 4D Molecular Therapeutics Institutional Ownership Aardvark Therapeutics Institutional Ownership This page (NASDAQ:INMB) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INmune Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access